Semler Scientific (NASDAQ:SMLR) Coverage Initiated at Cantor Fitzgerald

Key Points

• Cantor Fitzgerald has initiated coverage on Semler Scientific (NASDAQ:SMLR) with an "overweight" rating, further indicating market interest.
• The average analyst consensus rating on Semler Scientific is "Buy," with a price target of $82.00, despite mixed ratings from other firms.
• Semler Scientific reported a negative net margin of 60.69% in its latest quarterly earnings, with revenue of $8.84 million and an EPS of ($0.76).

Cantor Fitzgerald started coverage on shares of Semler Scientific (NASDAQ:SMLR - Free Report) in a research report report published on Monday morning, MarketBeat reports. The firm issued an overweight rating and a $61.00 price objective on the stock.

SMLR has been the topic of a number of other reports. Wall Street Zen lowered shares of Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd. Benchmark initiated coverage on shares of Semler Scientific in a research note on Tuesday, July 8th. They issued a "buy" rating and a $101.00 price objective on the stock. Finally, Maxim Group raised shares of Semler Scientific to a "strong-buy" rating and set a $95.00 price objective on the stock in a research note on Wednesday, July 9th. One analyst has rated the stock with a sell rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $82.00.

Semler Scientific Stock Performance

Shares of SMLR traded down $1.39 during mid-day trading on Monday, reaching $34.46. 857,642 shares of the company's stock were exchanged, compared to its average volume of 695,997. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.52 and a quick ratio of 0.51. The stock has a market capitalization of $475.13 million, a PE ratio of -13.20 and a beta of 1.39. The business's fifty day simple moving average is $38.22 and its 200-day simple moving average is $40.39. Semler Scientific has a 52-week low of $21.77 and a 52-week high of $81.56.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The business had revenue of $8.84 million for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.

Institutional Investors Weigh In On Semler Scientific

Institutional investors have recently made changes to their positions in the stock. Interchange Capital Partners LLC purchased a new stake in shares of Semler Scientific in the 1st quarter worth about $46,502,000. Capital International Investors acquired a new position in shares of Semler Scientific during the 4th quarter valued at about $30,813,000. Susquehanna Advisors Group Inc. acquired a new position in shares of Semler Scientific during the 4th quarter valued at about $26,928,000. Driehaus Capital Management LLC acquired a new stake in Semler Scientific during the 4th quarter worth approximately $10,122,000. Finally, Charles Schwab Investment Management Inc. increased its position in Semler Scientific by 226.1% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 158,576 shares of the company's stock worth $5,740,000 after purchasing an additional 109,951 shares in the last quarter. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.